Alerts will be sent to your verified email
Verify Email
CURIS
|
Curis Lifesciences
|
Sotac Pharmaceutical
|
Lincoln Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
63.11 % | -2.41 % | 15.1 % |
|
5yr average Equity Multiplier
|
1.91 | 5.52 | 1.26 |
|
5yr Average Asset Turnover Ratio
|
1.07 | 1.27 | 0.82 |
|
5yr Avg Net Profit Margin
|
8.37 % | 3.04 % | 14.59 % |
|
Price to Book
|
n/a | 2.69 | 1.57 |
|
P/E
|
n/a | 17.76 | 12.21 |
|
5yr Avg Cash Conversion Cycle
|
45.79 Days | 57.86 Days | -6.41 Days |
|
Inventory Days
|
77.61 Days | 44.94 Days | 43.91 Days |
|
Days Receivable
|
65.45 Days | 113.65 Days | 91.75 Days |
|
Days Payable
|
245.93 Days | 123.13 Days | 128.38 Days |
|
5yr Average Interest Coverage Ratio
|
5.43 | 3.95 | 63.13 |
|
5yr Avg ROCE
|
36.41 % | 21.68 % | 19.81 % |
|
5yr Avg Operating Profit Margin
|
16.92 % | 8.59 % | 18.35 % |
|
5 yr average Debt to Equity
|
0.12 | 2.1 | 0.0 |
|
5yr CAGR Net Profit
|
65.64 % | n/a | 5.76 % |
|
5yr Average Return on Assets
|
9.21 % | 3.18 % | 11.92 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
n/a | 72.85 % | 49.78 % |
|
Share Pledged by Promoters
|
n/a | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
n/a | 0.0 | 5.7 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
n/a | 0.0 | 0.0 |
|
Curis Lifesciences
|
Sotac Pharmaceutical
|
Lincoln Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Contract Type
|
Contract Type
|
-
|
-
|